Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction

European Journal of Nuclear Medicine

Volumn 23, Issue 3, 1996, Pages 272-279

  Tamaki, Nagara ^a   Tadamura, Eiji ^b   Kudoh, Takashi ^b   Hattori, Naoya ^b   Yonekura, Yoshiharu ^b   Nohara, Ryuji ^c   Sasayama, Shigetake ^c   Ikekubo, Katsuji ^d   Kato, Hiroshi ^d   Konishi, Junji ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Iodine 123 fatty acid; Myocardial infarction; Prognosis; Single photon emission tomography; Thallium 201

Indexed keywords

15 IODOPHENYL 3 METHYLPENTADECANOIC ACID; DECANOIC ACID DERIVATIVE; FATTY ACID DERIVATIVE; IODINE 123; THALLIUM 201; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC VALUE; EXERCISE TEST; FATTY ACID METABOLISM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE PERFUSION; HUMAN; MALE; PROGNOSIS; REGRESSION ANALYSIS; REST;

AGED; CORONARY ANGIOGRAPHY; FATTY ACIDS; FEMALE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS;

EID: 9044242094     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00837625     Document Type: Article

References (54)

1. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary artery disease: selection by univariate and multivariate analysis from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979; 59: 421-430.
2. Becker LC, Silverman KJ, Bulkley BH, Kallman CH, Mellits ED, Weisfeldt M. Comparison of early thallium-201 scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocardial infarction. Circulation 1983; 67: 1272-1282.
3. Bonow RO, Kent KM, Rosing DR, Gordon KK, Lakatos E, Borer JS, Bacharach SL, Green MV, Epstein SE. Execise-induced ischemia in mildly symptomatic patients with coronary artery disease and preserved left ventricular function: identification of subgroups at risk of death during medical therapy. N Engl Med 1984; 311: 1339-1345.
4. Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, Beller GA. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983; 68: 321-336.
5. Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, Pohost GM. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983; 1: 994-1001.
6. Wackers FJ, Russo DS, Russo D, Clements JP. Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. J Am Coll Cardiol 1985; 6: 27-30.
7. Ladenheim ML, Pollack BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, Diamond GA. Extent and severity of myocardial reperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986; 7: 464-471.
8. Gill JB, Ruddy TD, Newell JB, Finkelstein DM, Strauss HW, Boucher CA. Prognostic importance of thallium uptake by the lung during exercise in coronary artery disease. N Engl J Med 1988; 317: 1485-1489.
9. Kaul S, Lilly DR, Gascho JA, Watson DD, Gibson RS, Oliver CA, Ryan JM, Beller GA. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization. Circulation 1988; 77: 745-758.
10. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987; 10: 557-567.
11. Tamaki N, Yonekura Y, Yamashita K, Senda M, Saji H, Hashimoto T, Fudo T, Kambara H, Kawai C, Konishi J. Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction. Am J Cardiol 1988; 62: 202-208.
12. Brunken R, Kottou S, Nienaber CA, Schwaiger M, Ratib OM, Phelps ME, Schelbet HR. PET detection of viable tissue in myocardial segments with persistent defect at Tl-201 SPECT. Radiology 1989; 65: 65-73.
13. Eitzman D, Al-Aouar Z, Kanter HL, von Dahl J, Kirsh M, Deeb GM, Schwaiger M. Clinical outcome in patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20: 559-565.
14. Tamaki N, Kawamoto M, Takahashi N, Yonekura Y, Magata Y, Nohara R, Kambara H, Sasayama S, Hirata K, Ban T, Konishi J. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993; 22: 1621-1627.
15. DiCarli M, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsa Y, Schelbert HR, Phelps ME, Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
16. Tamaki N. Current status of viability assessment with positron emission tomography. J Nucl Cardiol 1994; 1: S40-S47.
17. Machulla HJ, Marsmann M, Dutschka K. Biochemical concept and synthesis of a radioiodinated phenyl fatty acid for in vivo metabolic studies of the myocardium. Eur J Nucl Med 1980; 5: 171-173.
18. 123I-labeled heptadecanoix acid in patients with angina pectoris. Eur J Nucl Med 1981; 6: 391-396.
19. 123I-phenyl pentadecanoic acid as a tracer of cardiac free fatty acid metabolism: experimental and clinical results. Eur Heart J 1985; 6: 39-47.
20. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986; 12: S39-S44.
21. Kaiser KP, Geuting B, Grossmann K, et al. Tracer kinetics of 15-(ortho-123/131I-phenyl)-pentadecanoic acid (oPPA) and 15-(para-123/131I-phenyl)-pentadecanoic acid (pPPA) in animals and man. J Nucl Med 1990; 31: 1608-1616.
22. Kropp J, Lkungu J, Kirchhoff PG. Single photon emission tomography imaging of myocardial oxidative metabolism with 15-(p-(I-123) iodophenyl) pentadecanoic acid in patients with coronary artery disease and aorta-coronary bypass grafting surgery. Eur J Nucl Med 1991; 18: 467-474.
23. Herich MM, Vester E, von der E, Herzog H, Kuikka JT, Feinendegen LE. The comparison of 2-18-F-2-deoxyglucose and 15-(ortho-I-123-phenyl) pentadecanoic acid uptake in persistent defects on thallium-201 tomography in myocardial infarction. J Nucl Med 1991; 32: 1352-1357.
24. Murray G, Schad N, Ladd W, Allie D, Zwagg RV, Avet P, Rockett J. Metabolic cardiac imaging in severe coronary artery disease: assessment of viability with iodine-123-iodophenyl pentadencanoic acid and multicrystal gama camera and correlation with biopsy. J Nucl Med 1992; 33: 1269-1277.
25. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, Nohara R, Kambara H, Kawai C, Ibekubo K, Kato H. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid. J Nucl Med 1992; 33: 659-667.
26. Kawamoto M, Tamaki N, Yonekura Y, Tadamura E, Fujibayashi Y, Magata Y, Nohara R, Sasayama S, Ikekubo K, Kato H, Konishi J. Combined study of I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994; 8: 47-54.
27. Tamaki N, Kawamoto M. The use of iodinated free fatty acids for assessing fatty acid metabolism. J Nucl Cardiol 1994; 1: S72-S78.
28. Rocco T, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990; 66: 158-163.
29. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl Med 1990; 323: 141-146.
30. Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, Konishi J. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990; 66: 394-399.
31. Tamaki N, Ohtani H, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med 1990; 31: 1617-1623.
32. Tamaki N, Yonekura Y, Mukai T, Fujita T, Nohara R, Kadota K, Kambara H, Kawai C, Torizuka K, Ishii Y. Segmental analysis of stress thallium myocardial emission tomography for localization of coronary artery disease. Eur J Nucl Med 1984; 9: 99-105.
33. Tamaki N, Yonekura Y, Mukai T, Kodama S, Kadota K, Kambara H, Kawai C, Torizuka K. Stress thallium-201 transaxial emission computed tomography: quantitative versus qualitative analysis of coronary artery disease. J Am Coll Cardiol 1984; 14: 1213-1221.
34. Schelbert HR, Henze E, Phelps ME. Emission tomography of the heart. Semin Nucl Med 1980; 10: 355-373.
35. Bergmann SR, Fox KAA, Geltman EM, Sobel BE. Positron emission tomography of the heart. Prog Cardiovasc Dis 1985; 28: 165-194.
36. Schwaiger M, Hick R. The clinical roles of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565-578.
37. 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983; 67: 766-788.
38. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert HR. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
39. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M, Konishi Y, Hirata K, Ban T, Konishi J. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860-865.
40. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, Yamamoto K, Konishi J, Yokoyama A. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methyl pentadecanoic acid (BMIPP), in relation to ATP content. J Nucl Med 1990; 31: 1818-1822.
41. Fujibayashi Y, Som P, Yonekura Y, Knapp FF Jr, Tamaki N, Yamamoto K, Konishi J, Yokoyama A. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15(p-iodophenyl)-3-(R,S) methyl pentadecanoic acid (BMIPP), and correlation to ATP concentration II. Studies in salt-induced hypertensive rats. Nucl Med Biol 1992; 2: 62-66.
42. 123I-β-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med 1989; 15: 341-345.
43. Miller DD, Gill JB, Elmaleh D, Arez T, Boucher CA, Strauss HW. Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium. Circ Res 1988; 63: 681-692.
44. Kurata C, Kobayashi A, Yamazaki N. Dual-tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters. J Nucl Med 1989; 30: 80-87.
45. Saito T, Yasuda T, Gold HK, Leinbach R, Livni E, Elmaleh D, Callahan R, Marlai-Korbach M, Wilkinson R, Fischman AJ, Strauss HW. Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury. Nucl Med Commun 1991; 12: 663-675.
46. Kurata C, Taniguchi T, Aoshima S, Kobayashi A, Yamazaki N, Kawai H, Kaneko M. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33: 6-13.
47. 201Tl. Nucl Med Commun 1993; 14: 181-188.
48. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodopheyl)-3-R,S-methylpentadecanoid acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992; 19: 775-782.
49. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994; 21: 283-291.
50. Franken PR, Geeter FD, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and ionotropic reserve. J Nucl Med 1994; 35: 1758-1765.
51. Kawamoto M, Tamaki N, Yonekura Y, Magata Y, Tadamura E, Nohara R, Sasayama S, Konishi J. Significance of myocardial uptake of iodine-123-labeled beta-methyl iodophenyl pentadecanoic acid: comparison with kinetics of carbon-1 I-labeled palmitate in positron emission tomography. J Nucl Cardiol 1994; 1: 522-528.
52. Hamby RI, Davidson ET, Hilsenrath J. Functional and anatomical correlates of markedly abnormal stress tests. J Am Coll Cardiol 1984; 3: 1375-1381.
53. Waters DD, Bosch X, Bouchard A, et al. Comparison of clinical variables and variables derived from a limited predischarge exercise test as predictors of early and late mortality after myocardial infarction. J Am Coll Cardiol 1985; 5: 1-8.
54. Wilcox II, Freedman SB, Allman KC, et al. Prognostic significance of a predischarge exercise test in risk stratification during unstable angina pectoris. J Am Coll Cardiol 1992; 18: 677-683.